Advanced search
Publication Cover
Journal of Market Access & Health Policy Volume 7, 2019 - Issue 1
Journal homepage
1,952
Views
7
CrossRef citations to date
0
Altmetric
Original Research Article

Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France

Emilie ClayHEOR, Creativ-Ceutical, Paris, FranceCorrespondence[email protected]
View further author information
,
Olivier CristeauHEOR, Creativ-Ceutical, Paris, FranceView further author information
,
Romain ChafaieNational Market Access & Price, ROCHE SAS, Boulogne-Billancourt, FranceView further author information
,
Alexandrina PintaNational Market Access & Price, ROCHE SAS, Boulogne-Billancourt, FranceView further author information
,
Benjamin MazaleyratNational Market Access & Price, ROCHE SAS, Boulogne-Billancourt, FranceView further author information
&
Vincent CottinPulmonology Department, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University Claude Bernard Lyon 1, Lyon, FranceView further author information
Article: 1626171 | Received 22 Mar 2019, Accepted 24 May 2019, Published online: 24 Jun 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.